These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 29428402)
1. MSF challenges pneumococcal vaccine patent in India. Usher AD Lancet Infect Dis; 2018 Mar; 18(3):254-255. PubMed ID: 29428402 [No Abstract] [Full Text] [Related]
2. MSF criticises India's decision to grant pneumococcal vaccine patent to Pfizer. Dutta SS BMJ; 2017 Aug; 358():j4072. PubMed ID: 28860305 [No Abstract] [Full Text] [Related]
3. MSF challenges Novartis's action over Indian patent for imatinib. Mudur G BMJ; 2007 Jan; 334(7586):172. PubMed ID: 17255582 [No Abstract] [Full Text] [Related]
4. [Novartis should discontinue its patent case in India!]. PehrOlov P Lakartidningen; 2007 Feb 14-20; 104(7):524. PubMed ID: 17375688 [No Abstract] [Full Text] [Related]
5. Pneumococcal vaccination for Indian children. Levine OS; Cherian T Indian Pediatr; 2007 Jul; 44(7):491-6. PubMed ID: 17684301 [No Abstract] [Full Text] [Related]
6. Challenges to pneumococcal vaccine in India. Kanungo R Indian J Med Microbiol; 2013; 31(1):1-2. PubMed ID: 23508420 [No Abstract] [Full Text] [Related]
7. The new patent regime and disease priorities in India. Gupta I; Guin P; Trivedi M Glob Public Health; 2013; 8(1):37-54. PubMed ID: 22845021 [TBL] [Abstract][Full Text] [Related]
8. India: multi-national pharmaceutical company challenges patent law. Betteridge G HIV AIDS Policy Law Rev; 2007 May; 12(1):35, 38. PubMed ID: 17715534 [No Abstract] [Full Text] [Related]
9. Taking TRIPS to India--Novartis, patent law, and access to medicines. Mueller JM N Engl J Med; 2007 Feb; 356(6):541-3. PubMed ID: 17287473 [No Abstract] [Full Text] [Related]
10. International patent protection for HIV-related therapies: patent attorney's perspective. Pavento LC; Greene JL; McDonald JK Emory Int Law Rev; 2003; 17(2):919-31. PubMed ID: 15199935 [No Abstract] [Full Text] [Related]
11. Novartis challenges India's drug patent laws in Supreme Court. Billingsley M BMJ; 2012 Feb; 344():e1279. PubMed ID: 22354594 [No Abstract] [Full Text] [Related]
12. India remains on US trade "priority watch list" for failing to uphold international drug company patents. Arie S BMJ; 2013 May; 346():f2949. PubMed ID: 23657189 [No Abstract] [Full Text] [Related]
13. The Dunkel draft--a prescription for disaster. George T; Amalorpavanathan J; Begum Z Natl Med J India; 1992; 5(4):153-4. PubMed ID: 1304298 [No Abstract] [Full Text] [Related]
14. Intellectual property. Balancing innovation and access: patent challenges tip the scales. Higgins MJ; Graham SJ Science; 2009 Oct; 326(5951):370-1. PubMed ID: 19833944 [No Abstract] [Full Text] [Related]